Then you look at market cap potential. Ramp capacity at three months, six months, one year, two years and three years out. You factor in GBM is one of the three most difficult cancers to treat, account for speculation regarding combination trials for DCVax-l with csf1r with poly-iclc for every fucking cancer indication, then imagine all the little bear POS here in orange and NWBO’s direct and hyperactive technologies piling on to make cancer death obsolete.
Market Data 
Markets 
AI
